Ortho Clinical Diagnostics Holdings plc is a diagnostics & research business based in the US. Ortho Clinical Diagnostics Holdings plc shares (OCDX) are listed on the NASDAQ and all prices are listed in US Dollars. Ortho Clinical Diagnostics Holdings plc employs 4,500 staff and has a trailing 12-month revenue of around $1.9 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $20.23 |
|---|---|
| 52-week range | $15.14 - $21.82 |
| 50-day moving average | $19.71 |
| 200-day moving average | $18.56 |
| Wall St. target price | $24.82 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | N/A |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $20.23 from 2021-05-26
| 1 week (2024-07-13) | N/A |
|---|---|
| 1 month (2024-06-20) | N/A |
| 3 months (2024-04-20) | N/A |
| 6 months (2024-01-20) | N/A |
| 1 year (2023-07-20) | N/A |
|---|---|
| 2 years (2022-07-20) | N/A |
| 3 years (2021-07-23) | 21.26 |
| 5 years (2019-07-20) | N/A |
Valuing Ortho Clinical Diagnostics Holdings plc stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ortho Clinical Diagnostics Holdings plc's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ortho Clinical Diagnostics Holdings plc's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $438.9 million.
The EBITDA is a measure of a Ortho Clinical Diagnostics Holdings plc's overall financial performance and is widely used to measure a its profitability.
To put Ortho Clinical Diagnostics Holdings plc's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $1.9 billion |
|---|---|
| Operating margin TTM | 8.34% |
| Gross profit TTM | $880.4 million |
| Return on assets TTM | 1.97% |
| Return on equity TTM | 0% |
| Profit margin | -8.03% |
| Book value | N/A |
| Market Capitalization | $4.7 billion |
TTM: trailing 12 months
There are currently 2.7 million Ortho Clinical Diagnostics Holdings plc shares held short by investors – that's known as Ortho Clinical Diagnostics Holdings plc's "short interest". This figure is 10.4% up from 2.4 million last month.
There are a few different ways that this level of interest in shorting Ortho Clinical Diagnostics Holdings plc shares can be evaluated.
Ortho Clinical Diagnostics Holdings plc's "short interest ratio" (SIR) is the quantity of Ortho Clinical Diagnostics Holdings plc shares currently shorted divided by the average quantity of Ortho Clinical Diagnostics Holdings plc shares traded daily (recently around 869855.22875817). Ortho Clinical Diagnostics Holdings plc's SIR currently stands at 3.06. In other words for every 100,000 Ortho Clinical Diagnostics Holdings plc shares traded daily on the market, roughly 3060 shares are currently held short.
To gain some more context, you can compare Ortho Clinical Diagnostics Holdings plc's short interest ratio against those of similar companies.
However Ortho Clinical Diagnostics Holdings plc's short interest can also be evaluated against the total number of Ortho Clinical Diagnostics Holdings plc shares, or, against the total number of tradable Ortho Clinical Diagnostics Holdings plc shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ortho Clinical Diagnostics Holdings plc's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Ortho Clinical Diagnostics Holdings plc shares in existence, roughly 10 shares are currently held short) or 0.0294% of the tradable shares (for every 100,000 tradable Ortho Clinical Diagnostics Holdings plc shares, roughly 29 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ortho Clinical Diagnostics Holdings plc.
Find out more about how you can short Ortho Clinical Diagnostics Holdings plc stock.
We're not expecting Ortho Clinical Diagnostics Holdings plc to pay a dividend over the next 12 months.
Ortho Clinical Diagnostics Holdings plc engages in the vitro diagnostics business worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company also engages in contract manufacturing activities; and provides orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. The company was founded in 1939 and is headquartered in Raritan, New Jersey. .
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.